Why the study?
Does aortic valve repair improve survival compared to aortic valve replacement in patients with active infective endocarditis?
Does aortic valve repair improve survival compared to aortic valve replacement in patients with active infective endocarditis?
Aortic valve repair for active infective endocarditis may offer a survival benefit over replacement, though it carries a higher risk of late failure, particularly in patients with bicuspid anatomy requiring large patches.
Answers are grounded in this paper and cite their sources.
Repair may be associated with better survival than replacement in active endocarditis; leaves open need for randomized trials on reoperation risk.
OBJECTIVES: Aortic valve repair has advantages over replacement in stable aortic regurgitation. It is unclear whether this is similar in active endocarditis. METHODS: From January 2000 to July 2009, 100 patients (age 54.9±15.1 years) underwent surgery for aortic valve endocarditis. Thirty-three patients were treated by valve repair (I) and 67 underwent valve replacement (II: 51 biologic, 10 mechanical valves, 6 Ross operations). In Group I, cusp and root lesions were treated by autologous pericardial patches. A root abscess was present in 32 cases (I: 27%, II 34%; P=0.82). Concomitant procedures (n=49) were mitral repair (I: 10, II: 11; P=0.12) and coronary bypass (I: 4, II: 11; P=0.77). All patients were followed. Cumulative follow-up was 268 patient-years (mean 2.7±3.0 years). In a retrospective analysis, we analysed the outcome. RESULTS: Hospital mortality was 15% (I: 9%, II: 18%; P=0.37). Survival at 5 years was significantly better after repair (I: 88%, II 65%; P=0.047). Ten patients were reoperated (I: 35%, II: 10%; P=0.021) between 1 month and 5 years postoperatively. Actuarial freedom from aortic regurgitation of grade II or higher was 80% at 5 years (I: 66%, II: 87%; P=0.066). In Group I, this was influenced by aorto-ventricular (AV) morphology (tricuspid 80%, bicuspid 50%; P=0.0045). Freedom from reoperation in reconstructed tricuspid valves (n=20) was 87% at 5 years, which was identical to Group II (P=0.40). At 5 years, freedom from thromboembolic events was 93% (I: 100%, II: 90%; P=0.087) and that from bleeding complications was 100%. CONCLUSIONS: AV repair for active endocarditis seems to lead to better survival compared with replacement. The use of large patches in combination with bicuspid anatomy results in increased risk of late failure.
No takes yet. Share an insight, caveat, or question.
Mayer et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: